Table 2.

The 28-day and 90-day mortality rate in ACLF patients with and without cirrhosis

	28-day mortality rate				90-day mortality rate
	Cirrhosis	Non-cirrhosis	OR (95%CI)	p-value	Cirrhosis	Non-cirrhosis	OR (95%CI)	p-value
Overall	26.5% (169/637)	47.6% (468/984)	2.51 (2.02–3.12)	< 0.001	38.5% (245/637)	57.3% (564/984)	2.15 (1.75–2.63)	< 0.001
ARLD	23.6% (100/423)	49.9% (217/435)	3.22 (2.40–4.31)	< 0.001	35.2% (149/423)	58.4% (254/435)	2.58 (1.96–3.40)	< 0.001
HBV infection	39.8% (39/98)	38.6% (68/176)	0.95 (0.57–1.58)	0.90	46.9% (46/98)	48.9% (86/176)	1.08 (0.66–1.77)	0.80
HCV	10% (1/10)	37.5% (12/32)	5.40 (0.61–48.08)	0.10	30.0non% (3/10)	59.4% (19/32)	3.41 (0.74–15.68)	0/10
NASH	40.5% (15/37)	59.1% (26/44)	2.11 (0.87–5.16)	0.10	67.6% (25/37)	61.4% (27/44)	0.76 (0.31–1.91)	0.56
Cryptogenic	24.3% (9/37)	47.7% (51/107)	2.83 (1.22–6.57)	0.01	32.4% (12/37)	57.9% (62/107)	2.87 (1.31–6.31)	0.007
Other causes	19.2% (5/26)	47.2% (17/36)	3.76 (1.16–12.16)	0.02	34.6% (9/26)	63.9% (23/36)	3.34 (1.16–9.61)	0.02

ARLD alcohol-related liver disease, HBV hepatitis B virus, HCV hepatitis C virus, NASH non-alcoholic steatohepatitis